Načítá se...
Oral selenium supplementation has no effect on PSA velocity in men undergoing active surveillance for localized prostate cancer
INTRODUCTION: The Nutritional Prevention of Cancer Trial demonstrated a 52% lower incidence of prostate cancer in men supplemented with selenium. As a result, our study was designed to assess whether selenium supplementation attenuates the progression of prostate cancer. METHODS: A Phase 2 randomize...
Uloženo v:
| Vydáno v: | Cancer Prev Res (Phila) |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4533875/ https://ncbi.nlm.nih.gov/pubmed/20647337 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-09-0143 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|